Login / Signup

A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status.

Raveena RavikumarTristan Robert Alexander LaneAdarsh BabberSarah OnidaAlun Huw Davies
Published in: Phlebology (2020)
Daily NMES usage increases flow parameters, with twice daily usage improving QoL and clinical severity at 6 weeks in CVD patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • physical activity
  • chronic kidney disease
  • prognostic factors